University Health Network, Toronto: Carcinoma, Non-Small-Cell Lung trials
The registry lists 25 Carcinoma, Non-Small-Cell Lung studies with University Health Network, Toronto as lead sponsor. 7 are open to participants now and 1 have results posted.
Phase 1 1Phase 2 12No phase 12(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Lay Navigation Intervention for Patients With Lung CancerNot yet recruitingNCT07548788Not applicable
- ctDNA-Guided CURB for OPD mNSCLC on TKI (CURB-TKI)Not yet recruitingNCT06813664Phase 2
- Pneumonitis Prevention Protocol Using Pentoxifylline and α-tocopherol In Stage III Non-Small Cell Lung Cancer Patients Undergoing ChemoradiationRecruitingNCT06634056Phase 2
- Using ctDNA to Detect Minimal Residual Disease After Lung Cancer ResectionRecruitingNCT05254782
- Using ctDNA to Determine Therapies for Lung CancerRecruitingNCT04966663Phase 2
- Genomic Investigation of Unusual RespondersRecruitingNCT03740503
- Stereotactic Radiotherapy (SBRT) of Lung MetastasisRecruitingNCT01803542Phase 2
- A Phase I/Ib Study of MEK162, a MEK Inhibitor, in Combination With Carboplatin and Pemetrexed in Patients With Non-squamous Carcinoma of the LungCompletedNCT02185690Phase 1Results posted
- --SuPERIOR Trial--TerminatedNCT06191250Phase 2
- Study of Nivolumab-Ipilimumab and cfDNA in Lung CancerTerminatedNCT04966676Phase 2
- Accelerating Lung Cancer Diagnosis Through Liquid BiopsyActive, not recruitingNCT04863924
- A Multi-Cancer, Multi-State, Platform Study of Durvalumab (MEDI4736) and Oleclumab (MEDI9447) in Pancreatic Adenocarcinoma, Non-Small Cell Lung Cancer and Squamous Cell Carcinoma of the Head and Neck to Correlate Clinical, Molecular and Immunologic Parameters With DNA MethylationWithdrawnNCT04262388Phase 2
- Study of Crizotinib for ROS1 and MET Activated Lung CancerCompletedNCT04084717Phase 2
- Palliative Thoracic ImmunoRTActive, not recruitingNCT03705806
- Outcomes Following Omission of Daily Routine Chest Radiographs Following Pulmonary ResectionCompletedNCT03704870Phase 2
- Achieving Value in Cancer Diagnostics: Blood Versus Tissue Molecular Profiling - a Prospective Canadian StudyCompletedNCT03576937
- PET CT Re-Planning NSCLC (4DCT-PET)CompletedNCT03403127Not applicable
- Phase II Lung Metcore - Preoperative Metformin for Lung CancerCompletedNCT03086733Phase 2
- Piloting the Feasibility of FLT-PET/CT Non-Small Cell Lung Cancer Managed With SBRTCompletedNCT02456246Not applicable
- Integrated Molecular Profiling in Advanced Cancers TrialActive, not recruitingNCT01505400
- Stereotactic Body Radiotherapy (RT) for Non-Small Cell Lung CancerCompletedNCT01480973Not applicable
- Computer-Generated Quality of Life Assessment Program for Advanced Non-Small Cell Lung Cancer Patients (LUNL2)CompletedNCT01337102Not applicable
- Observing Patients With Palliative Asymptomatic Centrally Located Advanced Non-small Cell Lung Carcinoma (NSCLC)CompletedNCT01279408
- Surgery for Early Lung Cancer With Preoperative Erlotinib (Tarceva): A Clinical Phase II Trial (SELECT)CompletedNCT00462995Phase 2
- Endobronchial Ultrasound vs Mediastinoscopy in NSCLCCompletedNCT00372203Phase 2